Year: 2025

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updated data on 13 participants from ongoing Phase 1b trial that continue to support safety and tolerability of tegoprubart for prevention of organ rejection in kidney transplantation Announced positive initial data from first three subjects with type 1 diabetes treated with tegoprubart as part of immunosuppression regimen following islet transplantation in investigator-initiated trial at UChicago Medicine Completed two financings totaling $135 million in combined gross proceeds, with funds expected to support operations through end of 2026 IRVINE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq:...

LONDON, Ontario, Jan. 13, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the Company will ring the closing bell at the Nasdaq MarketSite in Times Square, New York, on Friday, January 17, 2025. This event marks a significant milestone for Aduro following its recent uplisting to the Nasdaq Capital Market. The ceremony will be led by Ofer Vicus, CEO of Aduro, accompanied by members of the Company’s leadership team, Board of Directors, employees, and key stakeholders who have been instrumental in supporting Aduro’s journey. The live broadcast of the Nasdaq Closing...

MONTREAL, Jan. 13, 2025 (GLOBE NEWSWIRE) — Stingray Group Inc. (TSX: RAY.A; RAY.B) will release its financial results for the third quarter ended December 31, 2024, on Tuesday, February 4, 2025, after the markets close. Management will hold a conference call to discuss the financial results the next day, February 5, 2025, at 10:00 a.m. Eastern Time. Details of the Conference Call Via the internet at www.corporate.stingray.com Via telephone: (+1) 800-717-1738, Montreal (+1) 514-400-3792, Toronto (+1) 289-514-5100 or New York (+1) 646-307-1865 Conference Call Rebroadcast A rebroadcast of the conference call will be available until midnight, March 5, 2025, by dialing (+1) 888-660-6264, Toronto (+1) 289-819-1325 or New York (+1) 646-517-3975 and entering passcode 97537. About Stingray Stingray (TSX: RAY.A; RAY.B), a global music, media,...

New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility BANGKOK, Jan. 13, 2025 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the launch of its innovative lifetime egg freezing service in Asia. The innovative “one charge, no worries” fertility preservation solution is designed to serve the growing needs of women across Asia, and will allow customers to make a one-time payment to arrange for lifetime egg freezing. NewGen’s new service addresses a robust market opportunity, particularly in light of increasing demand for egg freezing services in the region. The global egg freezing and embryo...

After nearly 38 years with Jyske Bank – of these almost 16 years on the Group Executive Board – Niels Erik Jakobsen, Managing Director, has decided to retire in the course of the second quarter of 2025. Niels Erik Jakobsen was employed by Jyske Bank on 1 August 1987. He joined the Group Executive Board on 1 September 2009 and has been in charge of e.g. Capital Markets and most recently Personal Clients and Wealth Management. In addition, Niels Erik Jakobsen is Chairman of the Supervisory Boards of Jyske Bank’s subsidiaries Jyske Realkredit and Jyske Finans and on the Boards of BankInvest and Letpension. Kurt Bligaard Pedersen, Chairman of the Supervisory Board of Jyske Bank, states: ”Niels Erik Jakobsen has made a significant mark on Jyske Bank’s development over the years, and with his considerable knowledge and insight, especially...

CALGARY, Alberta, Jan. 13, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) is pleased to provide its preliminary outlook for 2025. All amounts presented are in U.S. Dollars (“USD”) unless otherwise stated. Outlook During 2025, Enerflex’s priorities include: (1) enhancing the profitability of core operations; (2) leveraging the Company’s leading position in core operating countries to capitalize on expected increases in natural gas and produced water volumes; and (3) maximizing free cash flow to strengthen Enerflex’s financial position, provide direct shareholder returns, and invest in selective customer supported growth opportunities. Enerflex’s preliminary outlook for 2025 reflects steady demand across its business lines and geographic regions. Operating results will be underpinned by...

Series  RIKV 25 0416 RIKV 25 0820Settlement Date  01/15/2025 01/15/2025Total Amount Allocated (MM)  29,935 23,300All Bids Awarded At (Price / Simple interest)  97.918 / 8.412 95.263 / 8.249Total Number of Bids Received  18 27Total Amount of All Bids Received (MM)  32,435 25,600Total Number of Successful Bids  15 24Number of Bids Allocated in Full  15 24Lowest Price / Highest Simple Interest Allocated  97.918 / 8.412 95.263 / 8.249Highest Price / Lowest Simple Interest Allocated  97.982 / 8.148 95.510 / 7.799Lowest Price / Highest Simple Interest Allocated in Full  97.918 / 8.412 95.263 / 8.249Weighted Average of Successful Bids (Price/Simple Interest)  97.932 / 8.354 95.331 / 8.125Best Bid (Price / Simple Interest)  97.982 / 8.148 95.510 / 7.799Worst Bid (Price / Simple Interest)  97.897 / 8.498 95.208 / 8.350Weighted...

Anchorage Alaska, Jan. 13, 2025 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) is pleased to announce assay results for gold and antimony from soil samples collected at the Stibium prospect have now been received and have identified high-grade resource targets within the previously identified 800m long by 400m wide zone at Stibium within the Company’s over 500km2 flagship Estelle Gold and Critical Minerals Project located in the Tintina Gold Belt in Alaska. HighlightsNew drill-ready broad structurally controlled gold and antimony zones identified at Stibium through systematic ground exploration.US grant applications for antimony and critical minerals development progressingAssay results for soil and rock chip samples taken as part of the 2024 follow-up reconnaissance...